US Navy cancels MASC programme, launches $2.1bn MUSV marketplace as the Golden Fleet strategy moves from concept to procurement
No Kings protests return to New York City for third time as nationwide mobilisation targets Trump administration policies
Read More 2 minute read Pharma Industry News Pfizer ends clinical Trials of DMD drug domagrozumab after disappointing results Pfizer, the US pharmaceutical giant, has announced the discontinuation of two ongoing clinical trials for its drug domagrozumab… bypharmanewsdailyAugust 31, 2018
